Literature DB >> 29777452

Revision of Surgical Margin under Frozen Section to Achieve R0 Status on Survival in Patients with Pancreatic Cancer.

Zi Yin1, Yu Zhou2, Baohua Hou2, Tingting Ma3, Min Yu2, Chuanzhao Zhang2, Xin Lu2, Zhixiang Jian4.   

Abstract

OBJECTIVE: The aim is to investigate whether additional resection based on intraoperative frozen section (FS) to a secondary R0(s) status are associated with different long-term survivals in pancreatic cancer patients, comparing to those with R1 or primary R0(p) status.
METHODS: A systematic literature search (PubMed, Embase, Science Citation Index, Springer-Link, and Cochrane Central Register of Controlled Trials) was performed to identify all studies published up to June 2017. Survivals of patients undergoing pancreatic surgery according to the results of FS and re-resection were pooled for analysis.
RESULTS: Five cohort studies were qualified for inclusion in this review with a total of 2980 patients. Long-term survival outcomes favored R0(p) resection as compared to R0(s) resection (HR = 1.58, 95%CI 1.24-2.01, P = 0.0002, I2 = 58%). No significant difference was observed for patients with or without additional resection at the time of surgery when positive FS was detected (HR = 0.98, 95CI% 0.65-1.47, P = 0.91, I2 = 81%).
CONCLUSIONS: The present study did not support the concept of achieving an R0 resection by intraoperative re-resection would benefit the patient's survival. R1 margin at the time of surgery is more like a marker of aggressive tumor biology. Future well-designed randomized controlled trials are needed to confirm the conclusion.

Entities:  

Keywords:  Frozen section; Pancreatic cancer; R1 margin; Survival

Mesh:

Year:  2018        PMID: 29777452     DOI: 10.1007/s11605-018-3806-x

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  32 in total

1.  FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer.

Authors:  Thierry Conroy; Françoise Desseigne; Marc Ychou; Olivier Bouché; Rosine Guimbaud; Yves Bécouarn; Antoine Adenis; Jean-Luc Raoul; Sophie Gourgou-Bourgade; Christelle de la Fouchardière; Jaafar Bennouna; Jean-Baptiste Bachet; Faiza Khemissa-Akouz; Denis Péré-Vergé; Catherine Delbaldo; Eric Assenat; Bruno Chauffert; Pierre Michel; Christine Montoto-Grillot; Michel Ducreux
Journal:  N Engl J Med       Date:  2011-05-12       Impact factor: 91.245

2.  Neoadjuvant FOLFIRINOX for borderline resectable pancreas cancer: a new treatment paradigm?

Authors:  Kathleen K Christians; Susan Tsai; Anna Mahmoud; Paul Ritch; James P Thomas; Lauren Wiebe; Tracy Kelly; Beth Erickson; Huamin Wang; Douglas B Evans; Ben George
Journal:  Oncologist       Date:  2014-02-25

3.  Frozen section of the pancreatic neck margin in pancreatoduodenectomy for pancreatic adenocarcinoma is of limited utility.

Authors:  Tony C Y Pang; Oliver Wilson; Manuel A Argueta; Thomas J Hugh; Angela Chou; Jaswinder S Samra; Anthony J Gill
Journal:  Pathology       Date:  2014-04       Impact factor: 5.306

4.  Value of intraoperative neck margin analysis during Whipple for pancreatic adenocarcinoma: a multicenter analysis of 1399 patients.

Authors:  David A Kooby; Neha L Lad; Malcolm H Squires; Shishir K Maithel; Juan M Sarmiento; Charles A Staley; N Volkan Adsay; Bassel F El-Rayes; Sharon M Weber; Emily R Winslow; Clifford S Cho; Kathryn A Zavala; David J Bentrem; Mark Knab; Syed A Ahmad; Daniel E Abbott; Jeffrey M Sutton; Hong Jin Kim; Jen Jen Yeh; Rachel Aufforth; Charles R Scoggins; Robert C Martin; Alexander A Parikh; Jamie Robinson; Yassar M Hashim; Ryan C Fields; William G Hawkins; Nipun B Merchant
Journal:  Ann Surg       Date:  2014-09       Impact factor: 12.969

5.  Downstaging in pancreatic cancer: a matched analysis of patients resected following systemic treatment of initially locally unresectable disease.

Authors:  K A Bickenbach; M Gonen; Laura H Tang; Eileen O'Reilly; Karyn Goodman; M F Brennan; M I D'Angelica; R P Dematteo; Y Fong; W R Jarnagin; P J Allen
Journal:  Ann Surg Oncol       Date:  2011-12-01       Impact factor: 5.344

6.  Total pancreatectomy (R0 resection) improves survival over subtotal pancreatectomy in isolated neck margin positive pancreatic adenocarcinoma.

Authors:  C Max Schmidt; Jeffrey Glant; Jordan M Winter; Jason Kennard; Jennifer Dixon; Qianqian Zhao; Thomas J Howard; James A Madura; Atilla Nakeeb; Henry A Pitt; John L Cameron; Charles J Yeo; Keith D Lillemoe
Journal:  Surgery       Date:  2007-10       Impact factor: 3.982

7.  Pancreatic ductal adenocarcinoma: is there a survival difference for R1 resections versus locally advanced unresectable tumors? What is a "true" R0 resection?

Authors:  Ioannis T Konstantinidis; Andrew L Warshaw; Jill N Allen; Lawrence S Blaszkowsky; Carlos Fernandez-Del Castillo; Vikram Deshpande; Theodore S Hong; Eunice L Kwak; Gregory Y Lauwers; David P Ryan; Jennifer A Wargo; Keith D Lillemoe; Cristina R Ferrone
Journal:  Ann Surg       Date:  2013-04       Impact factor: 12.969

8.  Microscopic margins and patterns of treatment failure in resected pancreatic adenocarcinoma.

Authors:  Jennifer L Gnerlich; Samuel R Luka; Anjali D Deshpande; Bernard J Dubray; Joshua S Weir; Danielle H Carpenter; Elizabeth M Brunt; Steven M Strasberg; William G Hawkins; David C Linehan
Journal:  Arch Surg       Date:  2012-08

9.  Margin clearance and outcome in resected pancreatic cancer.

Authors:  David K Chang; Amber L Johns; Neil D Merrett; Anthony J Gill; Emily K Colvin; Christopher J Scarlett; Nam Q Nguyen; Rupert W L Leong; Peter H Cosman; Mark I Kelly; Robert L Sutherland; Susan M Henshall; James G Kench; Andrew V Biankin
Journal:  J Clin Oncol       Date:  2009-04-27       Impact factor: 44.544

10.  Practical methods for incorporating summary time-to-event data into meta-analysis.

Authors:  Jayne F Tierney; Lesley A Stewart; Davina Ghersi; Sarah Burdett; Matthew R Sydes
Journal:  Trials       Date:  2007-06-07       Impact factor: 2.279

View more
  2 in total

1.  Impact of intraoperative margin clearance on survival following pancreatoduodenectomy for pancreatic cancer: a systematic review and meta-analysis.

Authors:  Emrullah Birgin; Erik Rasbach; Patrick Téoule; Felix Rückert; Christoph Reissfelder; Nuh N Rahbari
Journal:  Sci Rep       Date:  2020-12-17       Impact factor: 4.379

2.  Intraoperative Positive Pancreatic Parenchymal Resection Margin: Is It a True Indication of Completion Total Pancreatectomy after Partial Pancreatectomy for Pancreatic Ductal Adenocarcinoma?

Authors:  Ji-Hye Jung; So-Jeong Yoon; Ok-Joo Lee; Sang-Hyun Shin; Jin-Seok Heo; In-Woong Han
Journal:  Curr Oncol       Date:  2022-07-27       Impact factor: 3.109

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.